These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 2433030

  • 1. Elevation of transforming growth factor alpha and its relationship to the epidermal growth factor and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
    Yeh YC, Tsai JF, Chuang LY, Yeh HW, Tsai JH, Florine DL, Tam JP.
    Cancer Res; 1987 Feb 01; 47(3):896-901. PubMed ID: 2433030
    [Abstract] [Full Text] [Related]

  • 2. Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma.
    Sacco R, Leuci D, Tortorella C, Fiore G, Marinosci F, Schiraldi O, Antonaci S.
    Cytokine; 2000 Jun 01; 12(6):811-4. PubMed ID: 10843770
    [Abstract] [Full Text] [Related]

  • 3. Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals.
    Kimball ES, Bohn WH, Cockley KD, Warren TC, Sherwin SA.
    Cancer Res; 1984 Aug 01; 44(8):3613-9. PubMed ID: 6331653
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA, Gadelhak SA, El-Morsi DA, Abdelaziz MM, Abbas AT, El-Emshaty HM.
    Hepatogastroenterology; 2009 Aug 01; 56(94-95):1417-24. PubMed ID: 19950803
    [Abstract] [Full Text] [Related]

  • 5. Epidermal growth factor-related transforming growth factors in the urine of patients with hepatocellular carcinoma.
    Chuang LY, Tsai JH, Yeh YC, Chang CC, Yeh HW, Guh JY, Tsai JF.
    Hepatology; 1991 Jun 01; 13(6):1112-6. PubMed ID: 1646759
    [Abstract] [Full Text] [Related]

  • 6. Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis.
    Uhlman DL, Nguyen P, Manivel JC, Zhang G, Hagen K, Fraley E, Aeppli D, Niehans GA.
    Clin Cancer Res; 1995 Aug 01; 1(8):913-20. PubMed ID: 9816062
    [Abstract] [Full Text] [Related]

  • 7. [Detection of alpha-fetoproteins mRNA and melanoma antigen-1 mRNA in peripheral blood of patients with hepatocellular carcinoma and its clinical significance].
    Yang SZ, Dong JH, Zhu J, Li K, Zhang Y.
    Zhonghua Wai Ke Za Zhi; 2004 Sep 07; 42(17):1060-3. PubMed ID: 15498320
    [Abstract] [Full Text] [Related]

  • 8. Implications of serum basic fibroblast growth factor levels in chronic liver diseases and hepatocellular carcinoma.
    Hsu PI, Chow NH, Lai KH, Yang HB, Chan SH, Lin XZ, Cheng JS, Huang JS, Ger LP, Huang SM, Yen MY, Yang YF.
    Anticancer Res; 1997 Sep 07; 17(4A):2803-9. PubMed ID: 9252719
    [Abstract] [Full Text] [Related]

  • 9. Significance of circulating endothelial progenitor cells in hepatocellular carcinoma.
    Ho JW, Pang RW, Lau C, Sun CK, Yu WC, Fan ST, Poon RT.
    Hepatology; 2006 Oct 07; 44(4):836-43. PubMed ID: 17006919
    [Abstract] [Full Text] [Related]

  • 10. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Soresi M, Magliarisi C, Campagna P, Leto G, Bonfissuto G, Riili A, Carroccio A, Sesti R, Tripi S, Montalto G.
    Anticancer Res; 2003 Oct 07; 23(2C):1747-53. PubMed ID: 12820452
    [Abstract] [Full Text] [Related]

  • 11. The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma.
    Ikeguchi M, Iwamoto A, Taniguchi K, Katano K, Hirooka Y.
    J Exp Clin Cancer Res; 2005 Sep 07; 24(3):415-21. PubMed ID: 16270528
    [Abstract] [Full Text] [Related]

  • 12. Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine.
    Stromberg K, Hudgins WR.
    Cancer Res; 1986 Nov 07; 46(11):6004-10. PubMed ID: 3019543
    [Abstract] [Full Text] [Related]

  • 13. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
    Mazziotti G, Sorvillo F, Morisco F, Carbone A, Rotondi M, Stornaiuolo G, Precone DF, Cioffi M, Gaeta GB, Caporaso N, Carella C.
    Cancer; 2002 Dec 15; 95(12):2539-45. PubMed ID: 12467068
    [Abstract] [Full Text] [Related]

  • 14. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.
    Dong ZZ, Yao DF, Yao M, Qiu LW, Zong L, Wu W, Wu XH, Yao DB, Meng XY.
    Hepatobiliary Pancreat Dis Int; 2008 Jun 15; 7(3):288-95. PubMed ID: 18522884
    [Abstract] [Full Text] [Related]

  • 15. Association between serum hepatocyte growth factor and survival in untreated hepatocellular carcinoma.
    Vejchapipat P, Tangkijvanich P, Theamboonlers A, Chongsrisawat V, Chittmittrapap S, Poovorawan Y.
    J Gastroenterol; 2004 Dec 15; 39(12):1182-8. PubMed ID: 15622483
    [Abstract] [Full Text] [Related]

  • 16. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
    Hong WS, Hong SI, Park SY, Son Y, Lee YS, Chung YH, Yang SK, Suh DJ, Min YI.
    Anticancer Res; 1995 Dec 15; 15(6B):2777-80. PubMed ID: 8669863
    [Abstract] [Full Text] [Related]

  • 17. Vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma.
    Zhao J, Hu J, Cai J, Yang X, Yang Z.
    Chin Med J (Engl); 2003 May 15; 116(5):772-6. PubMed ID: 12875699
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
    Hsia CY, Huo TI, Chiang SY, Lu MF, Sun CL, Wu JC, Lee PC, Chi CW, Lui WY, Lee SD.
    Eur J Surg Oncol; 2007 Mar 15; 33(2):208-12. PubMed ID: 17140760
    [Abstract] [Full Text] [Related]

  • 19. [Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma].
    Zhao J, Hu J, Cai J.
    Zhonghua Zhong Liu Za Zhi; 2001 Sep 15; 23(5):389-92. PubMed ID: 11810769
    [Abstract] [Full Text] [Related]

  • 20. Serum ferritin in hepatocellular carcinoma.
    Zhou XD, Stahlhut MW, Hann HL, London WT.
    Hepatogastroenterology; 1988 Feb 15; 35(1):1-4. PubMed ID: 2452122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.